Search Results

InkSpace Imaging proudly announces that GE Healthcare has certified their Snuggle™ and Silhouette™ MRI body arrays.

GE HealthCare unveiled SIGNA MAGNUS, an FDA 510 pending head-only magnetic resonance scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR systems.

GE HealthCare, a leading global precision care innovator, reported financial results for the first quarter ended March 31, 2024.

GE HealthCare, is announcing that its Vice President and Chief Financial Officer, Jay Saccaro will be presenting at the following upcoming investor conferences.

Heart Hospital of New Mexico at Lovelace Medical Center and GE HealthCare announced HHNM as the first location in the United States to install GE HealthCare’s latest Allia Image Guided System Pulse, which was designed to provide exceptional image quality and improve workflow for the diagnosis and treatment of cardiovascular diseases.

GE HealthCare, a leader in precision care innovation, will host an investor day on Thursday, November 21, 2024, in New York, NY.

GE HealthCare and MediView XR, Inc. announce the first installation and clinical use of augmented reality solution OmnifyXR Interventional Suite at North Star Vascular and Interventional in Minnesota.

GE HealthCare has topped a U.S. Food and Drug Administration list of artificial intelligence enabled medical devices for the third year in a row with 72 listed 510 clearances or authorizations to date in the United States.

GE HealthCare, a leader in precision care innovation, will announce its first quarter 2024 financial results before the market opens on Tuesday, April 30, 2024.

GE HealthCare (Nasdaq: GEHC) announces the U.S. FDA 510(k) Clearance of IONIC Health’s nCommand Lite technology.